Keyword: Drug and Chemical Associated Technologies Association (DCAT)
News
10.06.2016
- Lonza Houston, part of the Swiss-based life sciences group Lonza, has signed a strategic manufacturing agreement with bluebird bio, a Cambridge, Massachusetts-based clinical-stage...
News
01.06.2016
- The European Commission has approved a subcutaneous formulation of Roche’s MabThera for chronic lymphocytic leukemia (CLL) which saves time and eases the treatment burden compared...
News
31.05.2016
- Large innovative US pharmaceutical companies will continue seeking bolt-on acquisitions as the need for larger transactions has declined, says the ratings agency Fitch, adding that...
News
28.04.2016
- French biotechnology company Abivax has signed a contract with API manufacturer PCAS group for the production and supply of ABX464, a drug candidate for treating HIV. Under the...
News
28.04.2016
- As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...
News
22.04.2016
- After giving it a priority review in January, the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax), a novel of drug that targets a subset of leukemia...
News
19.04.2016
- As the drug world’s M&A carousel continues to turn, British-Swedish drugmaker Astra Zeneca is being eyed as the latest contender to enter the race to buy US biotech firm Medivation...
News
13.04.2016
- The US Senate’s Special Committee on Aging plans to decide on Apr. 13 whether or not to open contempt proceedings against Valeant Pharmaceuticals CEO Michael Pearson. Pearson, who...
